Literature DB >> 19046917

Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy.

V Guastella1, G Mick.   

Abstract

This article proposes a strategy for the diagnosis and treatment of neuropathic pain due to diabetic peripheral sensory neuropathy, based on 15 years of experience in French pain-management centres and on the available literature. In the diabetic patient with chronic pain in the lower limbs, the first step in the diagnostic process is to identify the neuropathic origin of the pain. The second step is to evaluate the patient's medical history and make a rigorous baseline assessment of the neuropathic pain symptoms to determine an effective pain-management strategy. In the third step, adequate and well-tolerated treatment directed towards a variety of painful symptoms is selected, taking into account other co-morbidities such as anxiety and depression. This report reports on the clinical aspects of neuropathic pain exhibited by patients with diabetic sensory polyneuropathy, and the key factors in their diagnosis and treatment, based on the results of meta-analyses and on a recent expert consensus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046917     DOI: 10.1016/j.diabet.2008.09.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  11 in total

Review 1.  [Diabetic neuropathy].

Authors:  Monika Lechleitner; Heidemarie Abrahamian; Claudia Francesconi; Markus Kofler
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 2.  Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Authors:  Andrea M Vincent; Brian C Callaghan; Andrea L Smith; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

3.  Diabetes alters the blood glucose response to ketamine in streptozotocin-diabetic rats.

Authors:  Huayong Chen; Li Li; Hui Xia
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Synergistic interaction between metformin and sulfonylureas on diclofenac-induced antinociception measured using the formalin test in rats.

Authors:  Mario I Ortiz
Journal:  Pain Res Manag       Date:  2013-08-28       Impact factor: 3.037

5.  Effectiveness of dorsal root ganglion stimulation and dorsal column spinal cord stimulation in a model of experimental painful diabetic polyneuropathy.

Authors:  Eva Koetsier; Glenn Franken; Jacques Debets; Sander M J van Kuijk; Roberto S G M Perez; Bengt Linderoth; Elbert A J Joosten; Paolo Maino
Journal:  CNS Neurosci Ther       Date:  2018-09-23       Impact factor: 5.243

6.  Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe
Journal:  Pain Res Treat       Date:  2012-04-24

7.  Antidiabetic and Antioxidant Properties of Triticum aestivum in Streptozotocin-Induced Diabetic Rats.

Authors:  Yogesha Mohan; Grace Nirmala Jesuthankaraj; Narendhirakannan Ramasamy Thangavelu
Journal:  Adv Pharmacol Sci       Date:  2013-12-14

8.  Angiogenin gene polymorphism: A risk factor for diabetic peripheral neuropathy in the northern Chinese Han population.

Authors:  Hongli Wang; Dongsheng Fan; Yingshuang Zhang
Journal:  Neural Regen Res       Date:  2013-12-25       Impact factor: 5.135

9.  Resveratrol alleviates diabetic mechanical allodynia in rats by downregulating P2X3R.

Authors:  Yuanyuan Cui; Yuting Li; Jiayi Ning; Yajing Mi; Xiaolong Wang; Zhongying Qiu; Le Li; Xingchun Gou
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

10.  Vasomodulation of peripheral blood flow by focused ultrasound potentiates improvement of diabetic neuropathy.

Authors:  Joo-Shin Tan; Chou-Ching Lin; Gin-Shin Chen
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.